Using peripheral blood T-cells, it has been shown that a PI3Kδ selective inhibitor inhibits TCR stimulated IFNγ and IL-17 production from healthy subjects, and IL-5 and IL-13 production from patients with allergy [11]. This evidence concerns the gene IFNG and allergic disease.